ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO364

Association of Bartter Syndrome in a Filipino Patient with Overlap Syndrome

Session Information

Category: Fluid, Electrolytes, and Acid-Base Disorders

  • 1102 Fluid, Electrolyte, and Acid-Base Disorders: Clinical

Authors

  • Gular, Wilmark N., St. Luke's Medical Center-Global City, Taguig, NCR, Philippines
  • Ilagan-Asis, Ivy Kathryn Aquino, St. Luke's Medical Center-Global City, Taguig, NCR, Philippines
  • Juat, Abigail Kristine Santos, St. Luke's Medical Center-Global City, Taguig, NCR, Philippines
Introduction

Bartter Syndrome is a genetic tubulopathy resulting in hypokalemia and hypochloremic alkalosis. It has been reported to exist with autoimmune diseases. We describe, possibly the first case of an acquired Bartter Syndrome in a patient with Overlap syndrome.

Case Description

We present a 34-year old Filipino woman with two-month history of generalized weakness. Work-up revealed hypokalemia, urine potassium wasting, metabolic alkalosis consistent with Bartter Syndrome. Oral and intravenous potassium were given with return of potassium to normal. However, weakness persisted. EMG-NCV done showed findings of demyelinating polyneuropathy consistent with Guillain-Barre Syndrome. She was treated with Intravenous Immunoglobulin with resolution of the weakness.

The patient had recurrence of weakness two months later, this time with dysphagia. Physical exam revealed diffuse skin thickening with sclerodactyly with an mRSS score of 18 for Systemic sclerosis. ANA was at 1:160. Complements were low with high Anti-dsDNA pointing to lupus. Repeat EMG-NCV showed diffuse distal and proximal sensory-motor polyradiculoneuropathy suggestive of myositis. Rheumatoid factor was positive though she had no joint pains. Serum potassium was low at 3.4. Management included oral potassium with Spironolactone and Methylprednisolone Pulse Therapy which led to significant improvement.

Discussion

We presented a case of an acquired Bartter Syndrome with Overlap Syndrome (Systemic Sclerosis, SLE, pre-clinical Rheumatoid Arthritis and Myositis). This case highlighted the temporal evolution of autoimmune disease and its association with a renal tubular disorder. Management involved potassium supplementation and treatment of the underlying disorder.

Flexion contracture and Sclerodactyly of the hand foot. Skin thickening of the legs and feet